Old Web
English
Sign In
Acemap
>
authorDetail
>
David Presky
David Presky
Boehringer Ingelheim
Antibody
B-cell activating factor
Chemistry
Monoclonal antibody
Molecular biology
4
Papers
75
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
An optimally designed anti-human CD40 antibody with potent B cell suppression for the treatment of autoimmune diseases
2021
International Journal of Pharmaceutics
Helen Wu
Kerry-Leigh Ralph
Eliud Sepuldeva
Gale Hansen
Hua Li
Zhong-Fu Huang
Dongmei Liu
Michael Dziegelewski
Jennifer Ahlberg
Lee Frego
Steve Fogal
Susan van Tongeren
Christine Grimaldi
Tobias Litzenberger
David Presky
Sanjaya Singh
Scott Brodeur
Rachel Kroe-Barrett
Show All
Source
Cite
Save
Citations (0)
Unexpected Potency Differences between B-Cell–Activating Factor (BAFF) Antagonist Antibodies against Various Forms of BAFF: Trimer, 60-Mer, and Membrane-Bound
2016
Journal of Pharmacology and Experimental Therapeutics
Amy Marie Nicoletti
Cynthia Hess Kenny
Ashraf Khalil
Qi Pan
Kerry L. M. Ralph
Julie Ritchie
Sathyadevi Venkataramani
David Presky
Scott M. DeWire
Scott Brodeur
Show All
Source
Cite
Save
Citations (12)
Nouveaux anticorps anti-baff
2015
Scott Brodeur
Keith Canada
Pankaj Gupta
Amy Marie Nicoletti
Qi Pan
Sanjaya Singh
Michael Dziegelewski
Philip Nicholas Gorman
Ashraf Khalil
John Miglietta
David Presky
Tao Wu
Haiguang Xiao
Show All
Source
Cite
Save
Citations (0)
Selective targeting of the IL23 pathway: Generation and characterization of a novel high-affinity humanized anti-IL23A antibody
2015
mAbs
Sanjaya Singh
Rachel Kroe-Barrett
Keith Canada
Xiang Zhu
Eliud Sepulveda
Helen Wu
Yaqin He
Ernest L. Raymond
Jennifer Ahlberg
Lee Frego
Laura Amodeo
Katrina Mary Catron
David Presky
Jeffrey H Hanke
Show All
Source
Cite
Save
Citations (63)
1